Evidence map›Paper›PMID 26739815›Full record

Trial reportDiabetologia2016

Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans.

Bryan C Bergman, Joseph T Brozinick, Allison Strauss, Samantha Bacon, Anna Kerege, Hai Hoang Bui, Phil Sanders, Parker Siddall, Tao Wei, Melissa K Thomas and 2 more

Open access · bronzeAbstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Diabetologia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 1 pooled it
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 1 synthesis or guideline pooled it, 144 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Intramuscular diacylglycerol accumulates with acute hyperinsulinemia in insulin-resistant phenotypes.American journal of physiology. Endocrinology and metabolism · 2024
    Article
  20. Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Bryan C BergmanDivision of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, PO Box 6511, MS 8106, Aurora, CO, 80045, USA. Bryan.Bergman@ucdenver.edu.
Joseph T BrozinickEli Lilly and Company, Indianapolis, IN, USA.
Allison StraussDivision of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, PO Box 6511, MS 8106, Aurora, CO, 80045, USA.
Samantha BaconDivision of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, PO Box 6511, MS 8106, Aurora, CO, 80045, USA.
Anna KeregeDivision of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, PO Box 6511, MS 8106, Aurora, CO, 80045, USA.
Hai Hoang BuiEli Lilly and Company, Indianapolis, IN, USA.
Phil SandersEli Lilly and Company, Indianapolis, IN, USA.
Parker SiddallEli Lilly and Company, Indianapolis, IN, USA.
Tao WeiEli Lilly and Company, Indianapolis, IN, USA.
Melissa K ThomasEli Lilly and Company, Indianapolis, IN, USA.
Ming Shang KuoEli Lilly and Company, Indianapolis, IN, USA.
Leigh PerreaultDivision of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, PO Box 6511, MS 8106, Aurora, CO, 80045, USA.
Eli Lilly (United States) · USUniversity of Colorado Anschutz Medical Campus · US

Funding

PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BRYAN C BERGMAN · 1995 to 2026
$32.6M
Localization of saturated diacylglycerol and insulin sensitivity in humansR01DK089170 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BERGMAN, BRYAN C · 2010 to 2014
$1.4M
Intramuscular Triglyceride Turnover/Insulin SensitivityK01DK066219 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BERGMAN, BRYAN C · 2005 to 2009
$647k
NCRR NIH HHS RR-00036NIDDK NIH HHS KO1DK066219NIDDK NIH HHS P30 DK048520NIDDK NIH HHS R01 DK089170NIDDK NIH HHS R01DK089170
6 · The paper itself

Abstract

aims/hypothesesCeramides and other sphingolipids comprise a family of lipid molecules that accumulate in skeletal muscle and promote insulin resistance. Chronic endurance exercise training decreases muscle ceramides and other sphingolipids, but less is known about the effects of a single bout of exercise.

methodsWe measured basal relationships and the effect of acute exercise (1.5 h at 50% [Formula: see text]) and recovery on muscle sphingolipid content in obese volunteers, endurance trained athletes and individuals with type 2 diabetes.

resultsMuscle C18:0 ceramide (p = 0.029), dihydroceramide (p = 0.06) and glucosylceramide (p = 0.03) species were inversely related to insulin sensitivity without differences in total ceramide, dihydroceramide, and glucosylceramide concentration. Muscle C18:0 dihydroceramide correlated with markers of muscle inflammation (p = 0.04). Transcription of genes encoding sphingolipid synthesis enzymes was higher in athletes, suggesting an increased capacity for sphingolipid synthesis. The total concentration of muscle ceramides and sphingolipids increased during exercise and then decreased after recovery, during which time ceramide levels reduced to significantly below basal levels. CONCLUSIONS/

interpretationThese data suggest ceramide and other sphingolipids containing stearate (18:0) are uniquely related to insulin resistance in skeletal muscle. Recovery from an exercise bout decreased muscle ceramide concentration; this may represent a mechanism promoting the insulin-sensitising effects of acute exercise.

Indexed as

AdultBlotting, WesternCeramidesExerciseHumansInsulin ResistanceMuscle, SkeletalRestSphingolipidsCeramidesSphingolipidsAthlete’s paradoxInsulin sensitivityLipid composition

Identifiers

PMID26739815
OpenAlexW2227147122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.